Treatment preference, adherence and outcomes in patients with cancer: literature review and development of a theoretical model

References

• NICE. Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence. 2014. Available at: http://publications.nice.org.uk/medicines-adherence-cg76/ [Last accessed April 2014]
   Google Scholar
• Adherence to long term therapies: evidence for action. WHO adherence report. 2003. Available at: http://www.who.int/chp/knowledge/publications/adherence_report/en/ [Last accessed 23 April 2014]
   Google Scholar
• Khawali C, Ferraz MB, Zanella MT, Ferreira SR. Willingness to pay as patient preference to bariatric surgery. Health Expect 2011;17:73-81
   PubMedGoogle Scholar
• Gomes-Villas Boas LC, Foss MC, Freitas MC, Pace AE. Relationship among social support, treatment adherence and metabolic control of diabetes mellitus patients. Rev Lat Am Enfermagem 2012;20:52-8
   PubMed Web of Science ®Google Scholar
• Hodgkins P, Swinburn P, Solomon D, et al. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment. Patient 2012;5:33-44
   PubMedGoogle Scholar
• Abu-Rustum NR, Lee S, Correa A, Massad LS. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer. Gynecol Oncol 2001;81:88-91
   PubMed Web of Science ®Google Scholar
• Li BD, Brown WA, Ampil FL, et al. Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy. Ann Surg 2000;231:883-9
   PubMed Web of Science ®Google Scholar
• Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003;21:602-6
   PubMed Web of Science ®Google Scholar
• Borner MM, Schoffski P, de Wit R, et al. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer 2002;38:349-58
   PubMed Web of Science ®Google Scholar
• Twelves C, Gollins S, Grieve R, Samuel L. A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer. Ann Oncol 2006;17:239-45
   PubMed Web of Science ®Google Scholar
• BUPA. Home chemotherapy. 2014. Available at: http://www.bupa.com/media/357902/bazian_evidence_review_full_report-_final.pdf [Last accessed April 2014]
   Google Scholar
• Partridge AH, Archer L, Kornblith AB, Gralow J. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol 2010;28:2418-22
   PubMed Web of Science ®Google Scholar
• van der Weijden T, Legare F, Boivin A, et al. How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol. Implement Sci 2010;5:10
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-47
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Barber N, et al. Concordance, adherence and compliance in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). 2005. Available at: www.nets.nihr.ac.uk/__data/assets/pdf_file/0007/…/ES-08-1412-076.pdf [Last accessed April 2014]
   Google Scholar
• Adisa AO, Lawal OO, Adesunkanmi AR. Paradox of wellness and nonadherence among Nigerian women on breast cancer chemotherapy. J Cancer Res Ther 2008;4:107-10
   PubMed Web of Science ®Google Scholar
• Alam N, Shepherd FA, Winton T, et al. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer 2005;47:385-94
   PubMed Web of Science ®Google Scholar
• Blinman P, Alam M, Duric V, et al. Patients’ preferences for chemotherapy in non-small-cell lung cancer: a systematic review. Lung Cancer 2010;69:141-7
   PubMed Web of Science ®Google Scholar
• Borras JM, Sanchez-Hernandez A, Navarro M, et al. Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial. BMJ 2001;322:826
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Geller ML. Adherence to endocrine therapy for breast cancer. Oncology 2006;71:1-9
   PubMed Web of Science ®Google Scholar
• Gotay C, Dunn J. Adherence to long-term adjuvant hormonal therapy for breast cancer. Expert Rev Pharmacoecon Outcomes Res 2011;11:709-15
   PubMed Web of Science ®Google Scholar
• Grecula JC, Schuller DE, Rhoades CA, et al. Intensification regimen 2 for advanced head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 1999;125:1313-18
   PubMed Web of Science ®Google Scholar
• Hauber AB, Gonzalez JM, Coombs J, et al. Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST). Patient Prefer Adherence 2011;5:307-14
   PubMed Web of Science ®Google Scholar
• Lash TL, Fox MP, Westrup JL, et al. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 2006;99:215-20
   PubMed Web of Science ®Google Scholar
• Spoelstra SL, Given CW. Assessment and measurement of adherence to oral antineoplastic agents. Semin Oncol Nurs 2011;27:116-32
   PubMedGoogle Scholar
• van Kleffens T, van Baarsen B, van Leeuwen E. The medical practice of patient autonomy and cancer treatment refusals: a patients’ and physicians’ perspective. Soc Sci Med 2004;58:2325-36
   PubMed Web of Science ®Google Scholar
• Visram H, Kanji F, Dent SF. Endocrine therapy for male breast cancer: rates of toxicity and adherence. Curr Oncol 2010;17:17-21
   PubMed Web of Science ®Google Scholar
• Ychou M, Hohenberger W, Thezenas S, et al. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol 2009;20:1964-70
   PubMed Web of Science ®Google Scholar
• Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179-211
   Web of Science ®Google Scholar
• Prochaska JO, DiClemente CC. The transtheoretical approach. In Norcross JC, Goldfried MR (eds). Handbook of psychotherapy integration, 2nd edition. New York, NY: Oxford University Press, 2005:147-71
   Google Scholar
• Rosenstock IM, Strecheer VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q 1988;15:175-83
   PubMedGoogle Scholar
• Burke NJ, Joseph G, Pasick RJ, Barker JC. Theorizing social context: rethinking behavioral theory. Health Educ Behav 2009;36(5 Suppl):55-70S
   PubMed Web of Science ®Google Scholar
• Christie J, Jandorf L, Itkowitz S, et al. Sociodemographic correlates of stage of adoption for colorectal cancer screening in African Americans. Ethn Dis 2009;19:323-9
   PubMed Web of Science ®Google Scholar
• Dein S. Explanatory models of and attitudes towards cancer in different cultures. Lancet Oncol 2004;5:119-24
   PubMed Web of Science ®Google Scholar
• Patel UA, Thakkar KH, Hollowat N. Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital. Laryngoscope 2008;118:428-32
   PubMed Web of Science ®Google Scholar